Artificial Intelligence has suddenly gone from the fringes of science to being everywhere. So how did we get here? And where's this all heading? In this new series of Science Friction, we're finding out.
…
continue reading
Contenido proporcionado por Sound Optometry. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Sound Optometry o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
Player FM : aplicación de podcast
¡Desconecta con la aplicación Player FM !
¡Desconecta con la aplicación Player FM !
35: Dry AMD – Hope on the horizon
MP3•Episodio en casa
Manage episode 395857116 series 2912274
Contenido proporcionado por Sound Optometry. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Sound Optometry o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
Age-related macular degeneration (AMD) is the most common cause of sight loss in the UK, and the dry form is the most common type of the condition. In this episode, Michelle Hanratty visits a community practice in Harborne, Birmingham, to meet optometrist Bradley Warwick. Brad specialises in dry AMD, so Michelle and Brad discuss how to manage and counsel patients with the condition that currently has no treatment options. Later, one of Brad’s patients, Martin, joins the conversation to discuss how he copes with the gradual progression of dry AMD and geographic atrophy.
Finally, Michelle looks to the future to find some good news: the first treatments for dry AMD became available in the US last year. Clare Bailey, a consultant ophthalmologist at Bristol Eye Hospital, explains how the treatments work, which patients they would be most suitable for and the role that optometrists would play in referring patients. The two treatments are not yet approved for use in the UK, but Clare explains that a decision should be made in 2024.
This episode covers the GOC domains of Communication and Clinical Practice. Docet - dedicated to providing quality optometric education and professional development.
Finally, Michelle looks to the future to find some good news: the first treatments for dry AMD became available in the US last year. Clare Bailey, a consultant ophthalmologist at Bristol Eye Hospital, explains how the treatments work, which patients they would be most suitable for and the role that optometrists would play in referring patients. The two treatments are not yet approved for use in the UK, but Clare explains that a decision should be made in 2024.
This episode covers the GOC domains of Communication and Clinical Practice. Docet - dedicated to providing quality optometric education and professional development.
45 episodios
MP3•Episodio en casa
Manage episode 395857116 series 2912274
Contenido proporcionado por Sound Optometry. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Sound Optometry o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
Age-related macular degeneration (AMD) is the most common cause of sight loss in the UK, and the dry form is the most common type of the condition. In this episode, Michelle Hanratty visits a community practice in Harborne, Birmingham, to meet optometrist Bradley Warwick. Brad specialises in dry AMD, so Michelle and Brad discuss how to manage and counsel patients with the condition that currently has no treatment options. Later, one of Brad’s patients, Martin, joins the conversation to discuss how he copes with the gradual progression of dry AMD and geographic atrophy.
Finally, Michelle looks to the future to find some good news: the first treatments for dry AMD became available in the US last year. Clare Bailey, a consultant ophthalmologist at Bristol Eye Hospital, explains how the treatments work, which patients they would be most suitable for and the role that optometrists would play in referring patients. The two treatments are not yet approved for use in the UK, but Clare explains that a decision should be made in 2024.
This episode covers the GOC domains of Communication and Clinical Practice. Docet - dedicated to providing quality optometric education and professional development.
Finally, Michelle looks to the future to find some good news: the first treatments for dry AMD became available in the US last year. Clare Bailey, a consultant ophthalmologist at Bristol Eye Hospital, explains how the treatments work, which patients they would be most suitable for and the role that optometrists would play in referring patients. The two treatments are not yet approved for use in the UK, but Clare explains that a decision should be made in 2024.
This episode covers the GOC domains of Communication and Clinical Practice. Docet - dedicated to providing quality optometric education and professional development.
45 episodios
Todos los episodios
×Bienvenido a Player FM!
Player FM está escaneando la web en busca de podcasts de alta calidad para que los disfrutes en este momento. Es la mejor aplicación de podcast y funciona en Android, iPhone y la web. Regístrate para sincronizar suscripciones a través de dispositivos.